BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000;11:539-49. [PMID: 10703678 DOI: 10.1681/ASN.V113539] [Cited by in Crossref: 81] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Odai T, Terauchi M, Hirose A, Kato K, Miyasaka N. Bone Mineral Density in Premenopausal Women Is Associated with the Dietary Intake of α-Tocopherol: A Cross-Sectional Study. Nutrients 2019;11:E2474. [PMID: 31618965 DOI: 10.3390/nu11102474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Bergin P, Leggett A, Cardwell CR, Woodside JV, Thakkinstian A, Maxwell AP, McKay GJ. The effects of vitamin E supplementation on malondialdehyde as a biomarker of oxidative stress in haemodialysis patients: a systematic review and meta-analysis. BMC Nephrol 2021;22:126. [PMID: 33832458 DOI: 10.1186/s12882-021-02328-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zheng H, Huang X, Zhang Q, Katz SD. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney Int 2006;69:679-84. [PMID: 16395269 DOI: 10.1038/sj.ki.5000046] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
4 Hörl WH. Iron therapy for renal anemia: how much needed, how much harmful? Pediatr Nephrol 2007;22:480-9. [PMID: 17206511 DOI: 10.1007/s00467-006-0405-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
5 Kuo KL, Hung SC, Wei YH, Tarng DC. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 2008;19:1817-26. [PMID: 18495964 DOI: 10.1681/ASN.2007101084] [Cited by in Crossref: 65] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
6 Showkat A, Bastnagel WR, Hudson JQ. Effect of α -Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron. ISRN Nephrol 2014;2014:634515. [PMID: 24967245 DOI: 10.1155/2014/634515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Rubio CP, Cerón JJ. Spectrophotometric assays for evaluation of Reactive Oxygen Species (ROS) in serum: general concepts and applications in dogs and humans. BMC Vet Res 2021;17:226. [PMID: 34174882 DOI: 10.1186/s12917-021-02924-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Coates TD. Physiology and pathophysiology of iron in hemoglobin-associated diseases. Free Radic Biol Med 2014;72:23-40. [PMID: 24726864 DOI: 10.1016/j.freeradbiomed.2014.03.039] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 8.5] [Reference Citation Analysis]
9 Van Buren P, Velez RL, Vaziri ND, Zhou XJ. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol 2012;44:499-507. [PMID: 21744260 DOI: 10.1007/s11255-011-0028-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
10 Rapido F. The potential adverse effects of haemolysis. Blood Transfus 2017;15:218-21. [PMID: 28518048 DOI: 10.2450/2017.0311-16] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
11 Armaly Z, Abd El Qader A, Jabbour A, Hassan K, Ramadan R, Bowirrat A, Bisharat B. Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype. BMC Nephrol 2015;16:135. [PMID: 26268514 DOI: 10.1186/s12882-015-0119-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Liakopoulos V, Roumeliotis S, Bozikas A, Eleftheriadis T, Dounousi E. Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence? Oxid Med Cell Longev 2019;2019:9109473. [PMID: 30774749 DOI: 10.1155/2019/9109473] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
13 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
14 Yoon JH, Kim JY, Park JK, Ko SB. Oxidative damage markers are significantly associated with the carotid artery intima-media thickness after controlling for conventional risk factors of atherosclerosis in men. PLoS One 2015;10:e0119731. [PMID: 25806957 DOI: 10.1371/journal.pone.0119731] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
15 Liakopoulos V, Roumeliotis S, Gorny X, Dounousi E, Mertens PR. Oxidative Stress in Hemodialysis Patients: A Review of the Literature. Oxid Med Cell Longev 2017;2017:3081856. [PMID: 29138677 DOI: 10.1155/2017/3081856] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 13.0] [Reference Citation Analysis]
16 Videla LA, Valenzuela R. Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. Biofactors 2021. [PMID: 34687092 DOI: 10.1002/biof.1797] [Reference Citation Analysis]